Analysis Report on China's Antineoplastic MarketSunFAITH China Ltd.August 10, 2005 10 Pages - SKU: CJFQ1172138 |
| Countries covered: China The industrialized process causes the aggravation of environmental pollution, the growth of people's life expectancy, making the incidence of tumor higher. Because multi-links on the molecule and cells’ level that the tumor takes place, there is antineoplastic directed against each link on the market, there are many kinds of directions in the research of the antineoplastic. However, judging from the current domestic market, there is actually few innovative antineoplastic. Hence, a lot of in-depth work still has to be done in each link research of mechanism that makes tumor take place. With the improvement of people’s attention of tumor both internationally and domestically, it has already become the topic that people have increasingly cared about to resist the tumor. Draw the antineoplastic and the antineoplastic of living beings recombining from the Chinese herbal medicine has already become the hot spot, the international and domestic market prospects in the future are promising. |
More China Antibody Technologies Reports
Research Report on Chinese Monoclonal Antibody Industry, 2012 by
China Research and Intelligence Co., Ltd.
Antibody medicine is generally obtained from monoclonal antibody through genetic engineering, possessing the advantages of strong targeting and few drug side effects. At the present ...
China Monoclonal Antibody Industry Report, 2010-2011 by
Research in China
China has been engaging in the R&D of monoclonal antibody industry for a long time, but still lags far behind the European and American countries ...
Chinese Markets for Monoclonal Antibody by
Asia Market Information & Development Company
China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next five years, both production and demand will ...
China Antibodies by
General Biologic Group Ltd.
With a rapidly growing economy, cost advantages, a skilled workforce, and a governmental commitment to the sciences, China is becoming increasingly important in the global ...
See all reports like this >>
More China Reports
D&B Country RiskLine Report: China by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Country Report China February 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Country Report China January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
D&B Country Report: China by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Wine - BRIC (Brazil, Russia, India, China) Industry Guide by
MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
See all reports like this >>
Related Markets
Antibody Technologies Reports
- Triple Analysis: Protein Kinase Inhibitors, Antibodies and Peptides
- Triple Analysis: Melanoma, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Leukemia, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Antibodies
